RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
Problems Faced by Small and Medium Pharmaceutical Companies Small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports are confronted with several issues. These include: lack of expertise‚ training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes;
Premium Pharmacology Pharmaceutical industry Drug
According to the first class‚ the power point showed that the pharmaceutical industry is the most profitable industry. Based on the Porter’s five forces model‚ there are convincing explanation why the pharmaceutical industry has big profitability. For the threat of new entrants perspective‚ it is high. The pharmaceutical industry has a big barrier to prevent newcomers to enter this industry such as R&D costs‚ patents limitation‚ the long length of clinical time‚ the percentage of FDA to approve drug
Premium Pharmaceutical industry Pharmacology Mergers and acquisitions
IBUS 3312 - International Management Pharmaceutical Companies‚ Intellectual Property‚ and the Global AIDS Epidemic Analysis While this case is literally full of negative aspects‚ we will only focus on the main points for both arguments. Pharmaceutical companies want to be sure that the products they spend years and millions of dollars to create are not easily reproduced and sold at discount prices. The profits pharmaceuticals make of their patented products are supposed to refinance
Premium United Nations AIDS Developing country
Deontological Ethical Analysis of Direct-to-Consumer Pharmaceutical Marketing In Deontological ethics‚ morality of an action is based upon the particular action’s adherence to moral laws independent of their consequences (DeGeorge 62). Direct-to-consumer marketing of pharmaceuticals has had heated debate with logical arguments from those for‚ and for those against allowing such practices to exist. I do not believe the marketing of the prescription medication to be solely unethical but more
Premium Marketing Pharmacology Pharmaceutical industry
Counterfeit Drugs Problems and Solutions for the Indian Pharmaceutical Industry Introduction Counterfeit drugs have been around for much of the recent history of industrial-scale drug production in India and abroad. Although detailed data on counterfeit medicines are difficult to obtain by virtue of its very nature‚ a recent WHO report estimates the prevalence to be around 1% of sales in developed countries to over 10% in some developing countries1. The more important aspect of this global
Premium Pharmaceutical industry Authentication Pharmacology
The "Pharmaceutical Excipients Market [By Products (Carbohydrates‚ Oleochemicals‚ Petrochemicals‚ Polymers‚ Microcrystalline Cellulose‚ Sugar‚ Calcium carbonate)‚ By Functionality (Fillers‚ Binders‚ Lubricants‚ Preservatives)] – Global Forecast to 2018 " analyzes and studies the major market drivers‚ restraints‚ and opportunities in North America‚ Europe‚ Asia-Pacific‚ and the Rest of the World. Browse 112 market data tables with 48 figures spread through 315 pages and in-depth TOC on "Pharmaceutical
Premium North America Pharmacology Pharmaceutical industry
patients” (Abraham 2010:604). According to Abraham (2010)‚ pharmaceuticalization is currently on an upward spiral and this dramatic increase can be attributed to five different factors. These five explanations are biomedicalism‚ medicalization‚ pharmaceutical industry promotion and marketing‚ consumerism‚ and regulatory-state ideology or policy. Each of these explanatory factors are mutually interactive but competing and it will be explained how this is in the following paragraphs. The biomedicalization
Premium Attention-deficit hyperactivity disorder Pharmacology Medicine
products in Pakistan. Wellcome produces Septran‚ whereas the other two are Beecham’s products. The sales of each of these three products are approximately $6 million to $9 million‚ larger than the total sales of many medium sized companies in the pharmaceutical industry in Pakistan. The following table shows the value sales of the top 10 products: Table 2: THE VALUE SALES OF THE TOP 10 PRODUCTS | |
Premium Pharmaceutical industry Corporation Limited company
Quality Management on Domestic and Global Competition In Pakistan‚ Sanofi-Aventis and GlaxoSmithKline are pharmaceutical companies that market popular products and carry very similar medications. Companies like these have the mission and responsibility of providing medicines and vaccinations to better people’s live in different countries and communities. One of the largest and leading pharmaceutical companies in Pakistan is the Sanofi-Aventis Pakistan Limited. The chains put most of their focus on
Premium Pharmaceutical industry Pharmacology